Immix Biopharma Stock Forecast

Buy or Hold candidate since Oct 06, 2025 Gain 79.96%

The Immix Biopharma, Inc. stock price fell by -4.04% on the last day (Monday, 17th Nov 2025) from $4.21 to $4.04. During the last trading day the stock fluctuated 16.75% from a day low at $3.94 to a day high of $4.60. The price has fallen in 6 of the last 10 days but is still up by 10.99% over the past 2 weeks. Volume has increased on the last day by 329 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $6.05 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $4.24 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 74.73% during the next 3 months and, with a 90% probability hold a price between $5.13 and $7.41 at the end of this 3-month period.

IMMX Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen -4.04%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Immix Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.60 and $3.06. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Immix Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.80 and $3.72. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Immix Biopharma, Inc. finds support just below today's level at $3.80. If this is broken, then the next support from accumulated volume will be at $3.72 and $3.61.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.660 between high and low, or 16.75%. For the last week, the stock has had daily average volatility of 14.60%.

Our recommended stop-loss: $3.86 (-4.47%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IMMX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Immix Biopharma, Inc. to open at $4.19, and during the day (based on 14 day Average True Range), to move between $3.85 and $4.23, which gives a possible trading interval of +/-$0.388 (+/-10.08%) up or down from last closing price. If Immix Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 10.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.21 (4.21%) than the support at $3.80 (5.94%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immix Biopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immix Biopharma, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.330 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $4.19 ( 3.80%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk